Equinix, Inc. · EQIX · FY2026 Q1 · Calendar Q2 2026
EQIX Q1 2026: AI Inferencing Demand Lifts Revenue 10%, Guidance Raised Again
Equinix's Q1 2026 results reinforce the thesis that enterprise AI adoption is migrating from training to inferencing at the edge, driving sustained demand for colocation, interconnection, and liquid-cooled capacity. Recurring revenue grew 10% and Fabric revenue surged 26%, confirming that AI workloads are translating into durable interconnection revenue. Despite missing consensus on both EPS and revenue by roughly 2-3%, management raised full-year guidance for the second consecutive quarter to 10-11% revenue growth, backed by a $4.1B capex program and the AtNorth renewable-power acquisition. The market reaction was negative -- a 1.6% abnormal move on 2.1x volume with continued subsequent drift -- suggesting investors are weighing the capital intensity against the growth outlook.
Company context
Snapshot as of publicationEquinix, Inc. is a digital infrastructure company that connects businesses to their customers, employees, and partners inside interconnected data centers. The company operates a global platform of data centers, providing colocation, interconnection, and support services to a diverse range of customers. Equinix enables businesses to access various places, partners, and possibilities needed to accelerate their digital strategies.
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 1, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 29, 2026 |
| Guggenheim | Buy | Buy | Maintain | May 20, 2026 |
| Mizuho | Outperform | Outperform | Maintain | May 7, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | May 1, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 30, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Apr 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 30, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 28, 2026 |
| HSBC | Buy | Buy | Maintain | Apr 27, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 21, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 13, 2026 |
| Truist Securities | Buy | Buy | Maintain | Feb 18, 2026 |
| UBS | Buy | Buy | Maintain | Feb 12, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 12, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 12, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Jul 22, 2025 |
| Stifel | Buy | Buy | Maintain | Jun 26, 2025 |
| B of A Securities | Buy | Buy | Maintain | Jun 26, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 9, 2025 |
| TD Securities | Buy | Buy | Maintain | May 1, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Feb 13, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Dec 11, 2024 |
| CFRA | Hold | Buy | Downgrade | Sep 24, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Aug 13, 2024 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Aug 3, 2023 |
| Argus Research | Buy | Buy | Maintain | May 18, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | May 4, 2023 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Dec 14, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Dec 13, 2022 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 30, 2020 |
| Nomura | Buy | Buy | Maintain | Apr 17, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 13, 2020 |
| FBN Securities | Outperform | Outperform | Maintain | Nov 4, 2019 |
| Mitsubishi UFJ | Overweight | Overweight | Maintain | Sep 10, 2019 |
| Berenberg | Buy | Buy | Maintain | Jan 8, 2019 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | Oct 23, 2018 |
| Moffett Nathanson | Buy | Buy | Maintain | Apr 9, 2018 |
| Canaccord Genuity | Buy | Buy | Maintain | May 11, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Apr 7, 2017 |
| Pacific Crest | Overweight | Overweight | Maintain | Nov 16, 2015 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Jul 31, 2014 |
| Evercore Partners | Overweight | Overweight | Maintain | Apr 29, 2014 |
| PiperJaffray | Neutral | Overweight | Downgrade | Feb 20, 2014 |
| Piper Sandler | Neutral | Overweight | Downgrade | Feb 20, 2014 |
| Bank of America | Buy | Buy | Maintain | Aug 20, 2012 |
| Benchmark | Buy | Buy | Maintain | Jun 21, 2012 |
| Dougherty & Co. | Neutral | Buy | Downgrade | Mar 22, 2012 |
| Dougherty | Neutral | Neutral | Maintain | Mar 22, 2012 |
| Oxen Group | Sell | Sell | Maintain | Mar 14, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $1,034.86. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BTIG | Analyst unavailable | $1,210 | $1,034.87 | +16.9% | Jul 10, 2026 |
| Barclays | Analyst unavailable | $1,130 | $1,042.39 | +9.2% | Jul 1, 2026 |
| Deutsche Bank | Analyst unavailable | $1,207 | $1,073.68 | +16.6% | May 5, 2026 |
| Truist Financial | Analyst unavailable | $1,215 | $1,091.38 | +17.4% | May 1, 2026 |
| Scotiabank | Maher Yaghi | $1,120 | $1,074.48 | +8.2% | Apr 30, 2026 |
| Oppenheimer | Timothy Horan | $1,200 | $1,055 | +16.0% | Apr 30, 2026 |
| Evercore ISI | Analyst unavailable | $1,240 | $1,089.85 | +19.8% | Apr 28, 2026 |
| Guggenheim | Analyst unavailable | $1,235 | $1,108.89 | +19.3% | Apr 27, 2026 |
| HSBC | Analyst unavailable | $1,250 | $1,108.89 | +20.8% | Apr 27, 2026 |
| Wells Fargo | Analyst unavailable | $1,200 | $1,103.97 | +16.0% | Apr 21, 2026 |
| Barclays | Analyst unavailable | $1,109 | $1,052.98 | +7.2% | Apr 16, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $1,173 | $1,031.57 | +13.3% | Apr 9, 2026 |
| Morgan Stanley | Analyst unavailable | $1,075 | $961.68 | +3.9% | Feb 13, 2026 |
| Scotiabank | Maher Yaghi | $997 | $957.49 | -3.7% | Feb 12, 2026 |
| Stifel Nicolaus | Erik Rasmussen | $1,075 | $982.27 | +3.9% | Feb 12, 2026 |
| BMO Capital | Analyst unavailable | $1,050 | $978.61 | +1.5% | Feb 12, 2026 |
| Goldman Sachs | Michael Ng | $894 | $960.74 | -13.6% | Feb 12, 2026 |
| UBS | Analyst unavailable | $1,010 | $867.52 | -2.4% | Feb 12, 2026 |
| Guggenheim | Analyst unavailable | $985 | $867.52 | -4.8% | Feb 12, 2026 |
| Wells Fargo | Analyst unavailable | $975 | $867.52 | -5.8% | Feb 12, 2026 |
| HSBC | Analyst unavailable | $1,050 | $799.02 | +1.5% | Jan 15, 2026 |
| UBS | Analyst unavailable | $959 | $792.62 | -7.3% | Jan 14, 2026 |
| Barclays | Brendan Lynch | $870 | $793.57 | -15.9% | Jan 13, 2026 |
| Deutsche Bank | Analyst unavailable | $915 | $772.02 | -11.6% | Jan 6, 2026 |
| Goldman Sachs | Michael Ng | $795 | $747.88 | -23.2% | Dec 18, 2025 |
| Truist Financial | Anthony Hau | $973 | $779.17 | -6.0% | Nov 18, 2025 |
| BMO Capital | Ari Klein | $900 | $847.46 | -13.0% | Oct 30, 2025 |
| Daiwa | Analyst unavailable | $917 | $822 | -11.4% | Oct 22, 2025 |
| Truist Financial | Anthony Hau | $961 | $779.34 | -7.1% | Aug 7, 2025 |
| BMO Capital | Market Perform | $850 | $824.31 | -17.9% | Jun 26, 2025 |
| Wolfe Research | Andrew Rosivach | $978 | $831.05 | -5.5% | Mar 26, 2025 |
| RBC Capital | Jonathan Atkin | $1,025 | $973.57 | -1.0% | Dec 11, 2024 |
| CFRA | Kenneth Leon | $985 | $980.9 | -4.8% | Dec 3, 2024 |
| Truist Financial | Anthony Hau | $1,090 | $980.9 | +5.3% | Nov 29, 2024 |
| BMO Capital | Ari Klein | $1,020 | $910.22 | -1.4% | Oct 31, 2024 |
| HSBC | Phani Kanumuri | $1,000 | $876.22 | -3.4% | Oct 4, 2024 |
| BMO Capital | Ari Klein | $975 | $883 | -5.8% | Oct 1, 2024 |
| Stifel Nicolaus | Erik Rasmussen | $960 | $883 | -7.2% | Oct 1, 2024 |
| CFRA | Kenneth Leon | $900 | $877.48 | -13.0% | Sep 23, 2024 |
| Mizuho Securities | Omotayo Okusanya | $971 | $861.44 | -6.2% | Sep 12, 2024 |
| Argus Research | Marie Ferguson | $900 | $817.98 | -13.0% | Aug 28, 2024 |
| Truist Financial | Anthony Hau | $935 | $824 | -9.6% | Aug 21, 2024 |
| Wells Fargo | Eric Luebchow | $875 | $798.86 | -15.4% | Jul 23, 2024 |
| Mizuho Securities | Vikram Malhotra | $873 | $775.96 | -15.6% | Jul 10, 2024 |
| Goldman Sachs | James Schneider | $870 | $756.6 | -15.9% | Jul 1, 2024 |
| Stifel Nicolaus | Erik Rasmussen | $920 | $761.06 | -11.1% | Jun 6, 2024 |
| RBC Capital | Jonathan Atkin | $922 | $766.12 | -10.9% | May 28, 2024 |
| BMO Capital | Ari Klein | $965 | $811.64 | -6.8% | Mar 21, 2024 |
| Truist Financial | Anthony Hau | $815 | $766.48 | -21.2% | Jun 27, 2023 |
| Loop Capital Markets | Ari Klein | $870 | $785.79 | -15.9% | Jun 16, 2023 |
| BNP Paribas | Analyst unavailable | $886 | $715.55 | -14.4% | Dec 14, 2022 |
| Deutsche Bank | Analyst unavailable | $680 | $639.92 | -34.3% | Nov 17, 2022 |
| RBC Capital | Analyst unavailable | $720 | $660.6 | -30.4% | Nov 14, 2022 |
| Oppenheimer | Timothy Horan | $750 | $652.21 | -27.5% | Jul 28, 2022 |
| Goldman Sachs | Analyst unavailable | $765 | $647.31 | -26.1% | Jul 12, 2022 |
| Jefferies | Jonathan Petersen | $790 | $648.57 | -23.7% | Jul 11, 2022 |
| Argus Research | Jacob Kilstein | $700 | $651.79 | -32.4% | May 23, 2022 |
| Credit Suisse | Analyst unavailable | $718 | $740.64 | -30.6% | Apr 28, 2022 |
| Credit Suisse | Analyst unavailable | $714 | $745.41 | -31.0% | Apr 25, 2022 |
| Citigroup | Michael Rollins | $950 | $763 | -8.2% | Apr 3, 2022 |
| Credit Suisse | Sami Badri | $673 | $688.64 | -35.0% | Feb 17, 2022 |
| Wells Fargo | Eric Luebchow | $775 | $688.64 | -25.1% | Feb 17, 2022 |
| J.P. Morgan | Richard Choe | $860 | $688.64 | -16.9% | Feb 17, 2022 |
| Stifel Nicolaus | Erik Rasmussen | $825 | $688.64 | -20.3% | Feb 17, 2022 |
| Goldman Sachs | Brett Feldman | $840 | $688.64 | -18.8% | Feb 17, 2022 |
| UBS | John Hodulik | $845 | $688.64 | -18.3% | Feb 17, 2022 |
| Jefferies | Jonathan Petersen | $750 | $670.68 | -27.5% | Feb 16, 2022 |
| Raymond James | Frank Louthan | $950 | $797.26 | -8.2% | Nov 4, 2021 |
| Truist Financial | Gregory P Miller | $925 | $777.46 | -10.6% | Jul 29, 2021 |
Track every rating change on EQIX the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session closeFollow EQIX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Versus Q4 2025, three things shifted. First, the AI narrative moved from broad workload expansion to specific inferencing and agentic-AI use cases, with 110 network nodes from top AI model providers and neo clouds now deployed and large-capacity Fabric connections tripling year over year. Second, revenue growth guidance was raised from 9-10% to 10-11%. Third, Equinix announced a joint agreement with CPPIB to acquire AtNorth, adding approximately 800 MW of renewable capacity in the Nordics -- a new strategic vector not present last quarter. The project pipeline narrowed from 52 projects across 35 markets to 46 across 32 markets, including six new ExScale builds.
Guidance delta
Management raised full-year 2026 guidance across all three key metrics -- revenue, adjusted EBITDA, and AFFO -- versus the prior quarter's already-raised outlook. Revenue growth guidance moved from 9-10% to 10-11%. The capex program was set at $4.1 billion for the year, targeting mid-20% cash-on-cash returns. The guidance sentiment remains 'raised' for the second consecutive quarter.
Key takeaways
- Recurring revenue grew 10% year over year, with interconnection revenue up 9% and Fabric revenue up 26%.
- Approximately 60% of the largest Q1 deals were AI-related, with enterprise AI inferencing and edge workloads now central growth engines.
- Full-year 2026 guidance was raised to 10-11% revenue growth, with corresponding increases to adjusted EBITDA and AFFO outlook.
- Capex remains aggressive at $4.1 billion, focused on metro expansion and high-density, liquid-cooled facilities across 36 sites.
- The AtNorth acquisition adds roughly 800 MW of renewable power capacity in the Nordics, executed via a joint agreement with CPPIB.
- Both EPS ($4.20 vs. $4.30 estimate) and revenue ($2.44B vs. $2.52B estimate) missed consensus by approximately 2-3%, yet management raised guidance.
Management priorities
- Launch and scale the Distributed AI Hub and Fabric Intelligence offerings.
- Complete 46 major projects across 32 markets, including six new ExScale projects.
- Increase liquid-cooling deployments beyond the current 36 sites.
- Finalize the AtNorth acquisition to add renewable power capacity in the Nordics.
- Maintain aggressive capex program targeting mid-20% cash-on-cash returns.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T01:52:42.781387+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T01:52:42.779168+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.